A Case of Advanced Hepatocellular Carcinoma Died of Metabolic Encephalopathy on the Early Course of Treatment With Sorafenib

Acta Hepatologica Japonica - Japan
doi 10.2957/kanzo.50.595
Full Text
Abstract

Available in full text

Categories
Hepatology
Date
Authors
Publisher

Japan Society of Hepatology

Related search

Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Early Α-Fetoprotein Response Predicts Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

Journal of Hepatocellular Carcinoma
2015English

Sorafenib Treatment in Advanced Hepatocellular Carcinoma With Tumor Thrombus Nearly Occupying the Entire Right Atrium

Journal of Liver Cancer
2018English

A Clinical Phase II Study of Sorafenib in Advanced Hepatocellular Carcinoma

Anaplastology
2012English

Attenuation of Liver Stiffness in Sorafenib-Treated Patients With Advanced Hepatocellular Carcinoma

Hepatoma Research
2017English

The Microenvironmental and Metabolic Aspects of Sorafenib Resistance in Hepatocellular Carcinoma

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2020English

Triclosan Treatment Decreased the Antitumor Effect of Sorafenib on Hepatocellular Carcinoma Cells

OncoTargets and Therapy
OncologyPharmacology
2018English

Successful Treatment of Hepatocellular Carcinoma With Regorafenib After Sorafenib-Induced Hypersensitivity

Internal Medicine
Internal MedicineMedicine
2019English

A Case of Hepatocellular Carcinoma With Disappearance of Lymph Node Metastasis After Sorafenib Administration

Acta Hepatologica Japonica
Hepatology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy